Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 17;42 Suppl 3(Suppl 3):125512.
doi: 10.1016/j.vaccine.2023.12.022. Epub 2023 Dec 29.

Development of COVID-19 vaccine policy - United States, 2020-2023

Sara E Oliver  1 , Megan Wallace  2 , Evelyn Twentyman  2 , Danielle L Moulia  2 , Monica Godfrey  2 , Ruth Link-Gelles  2 , Sarah Meyer  2 , Katherine E Fleming-Dutra  2 , Elisha Hall  2 , JoEllen Wolicki  2 , Jessica MacNeil  2 , Beth P Bell  3 , Grace M Lee  4 , Matthew F Daley  5 , Amanda Cohn  6 , Melinda Wharton  2
Affiliations

Development of COVID-19 vaccine policy - United States, 2020-2023

Sara E Oliver et al. Vaccine. .

Abstract

COVID-19 vaccines represent a great scientific and public health achievement in the face of overwhelming pressures from a global pandemic, preventing millions of hospitalizations and deaths due to COVID-19 vaccines in the United States. Over 675 million doses of COVID-19 vaccines have been administered in the United States, and over 80% of the U.S. population has had at least 1 dose of a COVID-19 vaccine. Over the course of the COVID-19 pandemic in the United States, over one million people died from COVID-19, and over six million were hospitalized. It has been estimated that COVID-19 vaccines prevented more than 18 million additional hospitalizations and more than 3 million additional deaths due to COVID-19 in the United States. From the beginning of the COVID-19 pandemic in 2020 through June 2023, ACIP had 35 COVID-19 focused meetings and 24 votes for COVID-19 vaccine recommendations. ACIP had the critical task of rapidly and thoroughly reviewing emerging and evolving data on COVID-19 epidemiology and vaccines, as well as making comprehensive population-based recommendations for vaccine policy and considerations for implementation through a transparent and evidence-based framework. Safe and effective COVID-19 vaccines, recommended through transparent policy discussions with ACIP, remain the best tool we have to prevent serious illness, hospitalization and death from COVID-19.

Keywords: COVID-19; Vaccine policy.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. The Commonwealth Fund. Two years of US COVID-19 vaccines have prevented millions of hospitalizations and deaths. December 13, 2022. https://www.commonwealthfund.org/blog/2022/two-years-covid-vaccines-prev....
    1. Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration. https://www.fda.gov/advisory-committees/blood-vaccines-and-other-biologi....
    1. CDC; Advisory Committee on Immunization Practices. General Committee-Related Information. Atlanta, GA: US Department of Health and Human Services, CDC. https://www.cdc.gov/vaccines/acip/committee/index.html.
    1. CDC; Advisory Committee on Immunization Practices. ACIP Meeting Information. Atlanta, GA: US Department of Health and Human Services, CDC. https://www.cdc.gov/vaccines/acip/meetings/index.html.
    1. CDC; Advisory Committee on Immunization Practices. ACIP Live Meetings. YouTube. https://www.youtube.com/playlist?list=PLvrp9iOILTQb6D9e1YZWpbUvzfptNMKx2.

Substances

LinkOut - more resources